Search Results
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe.
Baxter to Host Annual Meeting of Stockholders in Virtual Format
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday, May 6, 2025 at 9 a.m., Central Time, as disclosed in Baxter's proxy statement for the 2025 Annual Meeting. Online access to the 2025 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2025 Annual Meeting in person.
Finding Her Calling, Inspiring Women Engineers
Stefanie Anderson, senior manager of engineering for Baxter's Infusion Therapies and Technologies business, wasn’t always certain of her engineering career path. However, she did have a guiding light in the industry – her mother. Throughout her career, Stefanie has been passionate about supporting her colleagues, just as Stefanie's mom did for her. We recently interviewed Stefanie about her career path and her inspiration.
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-activated Technology in Hospital Settings
Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company's first voice-activated technology, at the 2025 HIMSS Global Healthcare Conference.
Baxter to Present at Barclays 27th Annual Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Monday, September 8, 2025.
Baxter Reports Fourth-Quarter and Full-Year 2024 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its financial guidance for first-quarter and full-year 2025.
Baxter to Present at TD Cowen 45th Annual Health Care Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:10 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, September 1, 2025.
Baxter to Present at Raymond James & Associates' 46th Annual Institutional Investors Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:05 p.m. Eastern Time.
Finding the Right Notes
Stephen Hart turned his passion for performance and technology into a knack for Connected Care integration
Baxter to Present at Citi – 2025 Medtech & Life Sciences Access Day
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Tuesday, August 26, 2025.